Aclasta (Zoledronic acid) is an effective treatment of osteoporosis and is now available as a once yearly intravenous infusion in primary care. The infusion is funded under PHO clinical programmes for patient who meet PHARMAC Special Authority criteria.
Please see patient information about infusion
If you are concerned about your bone health please book to see one of our doctors for discussion. Our nurses are trained in given IV infusion and we offer this service in our clinic.